MedPath
NMPA Approval

Neostigmine Methylsulfate Injection

国药准字H20247239

October 11, 2024

国药准字H20057097

Drug Information

甲硫酸新斯的明注射液

注射剂

4ml:2mg

化学药品

October 11, 2024

Company Information

Applicant Company

浙江省台州市仙居县仙药路1号

Manufacturing Company

浙江省台州市仙居县福应街道现代工业集聚区兴业路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲硫酸新斯的明注射液 - NMPA 批准文号 | MedPath